Documentos relacionados

1. Low-dimensional neural ODEs and their application in pharmacokinetics.
2. Training the next generation of pharmacometric modelers: a multisector perspective.
3. The Finite Absorption Time (FAT) concept en route to PBPK modeling and pharmacometrics.
4. Machine Learning Models for Human <i>In Vivo</i> Pharmacokinetic Parameters with In-House Validation.
5. Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities.
6. Determination of the Number of Tissue Groups of Kinetically Distinct Transit Time in Whole-Body Physiologically Based Pharmacokinetic (PBPK) Models I: Theoretical Consideration of Bottom-Up Approach of Lumping Tissues in Whole-Body PBPK.
7. [Water in oil microemulsions for transdermal delivery of fluorouracil].
8. Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case study.
9. Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection.
10. Approaching sites of action of drugs in clinical pharmacology: New analytical options and their challenges.